U-M to conduct clinical trial to test AstraZeneca COVID-19 vaccine

Author | Kelly Malcom

Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2).

The study will look at how well the investigational vaccine works and how safe it is. U-M will begin recruiting hundreds of participants for the trial immediately, until the trial is full. U-M is one of several U.S. sites supporting the AstraZeneca trial, with the aim of including 30,000 individuals over a period of two years.

“The importance of a safe and effective vaccine against COVID-19 cannot be overstated. The AstraZeneca Phase III trial will bring answers as to the effectiveness of this vaccine. At the end of the day, this kind of rigorous clinical trial with the commitment of Michigan Medicine and other study sites to safety will be a key step in realizing a vaccine that will save lives when one is developed,” says Marschall Runge, M.D., Ph.D., Dean, U-M Medical School, Executive Vice President, Medical Affairs and CEO, Michigan Medicine.

The AstraZeneca trial is one of several vaccine trials being funded through a public/private partnership under the U.S. Department of Health and Human Services called Operation Warp Speed. It is designed to accelerate the development of a life-saving vaccine to prevent COVID-19, while maintaining standards for safety and efficacy.

“We are proud to advance the University of Michigan's outstanding legacy of excellence in vaccine trials with this important clinical trial partnership. We hope one day soon to be able to announce a successful vaccine against COVID-19 and save lives,” says Mark Schlissel, M.D., Ph.D., president of the University of Michigan.

Phase I/II trials of the vaccine in more than 1000 people were completed earlier this year and demonstrated increased antibody responses against SARS-CoV-2 and no serious adverse effects.

For more information about the study, visit https://www.uofmhealth.org/covid19-vaccine or email [email protected].

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories older woman walking with older man look from behind in their home
Health Lab
For traumatic brain injury caregivers, a mobile health intervention that may improve quality of life
It is important for caregivers to take care of their personal needs and mental health to efficiently give care to others. University of Michigan Health researchers are using a new app to remind caregivers to check in with their own physical and mental wellbeing.
yellow dices with different emotional faces on each side
Health Lab
Could personality tests help make bipolar disorder treatment more precise? 
Bipolar disorder treatment could become more precisely focused if guided by the results of personality tests that reveal personality styles, or combinations of personality traits.
Breaking Down Mental Health
Breaking Down Mental Health
Individualized Education Programs (IEPs) and 504 Plans
Define IEPs vs. 504 plans, create evidence-based plans by diagnosis, and help families navigate the IEP/504 process for effective support.
surgery-general-aerial
News Release
Michigan Medicine joins Longitude Health as new founding member
Longitude Health announced today that Michigan Medicine has joined the organization as a member.
mom and child with pacificer and older teen with pacifier in his mouth on other side of blue bench
Health Lab
Are parents waiting too long to stop pacifier use or thumb-sucking in kids?
A national poll looks at how parents tackle thumb-sucking and pacifier use —two habits that can benefit children but that can also be challenging to stop.
joe biden speaking
Health Lab
What does Joe Biden’s prostate cancer diagnosis mean for older patients?
Based on former President Joe Biden's recent diagnosis, a Michigan Medicine urologists discusses routine screening procedures and treatment outcomes.